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a b s t r a c t
In this study, the antioxidant and antidepressant-like activities of the semi-synthetic compound
α-phenylseleno citronellal (PhSeCIT) and the natural terpenoid R-citronellal (CIT) were evaluated. The
biological potential of PhSeCIT and CIT was evaluated by antioxidant in vitro assays, such as 1,1-diphenyl-
2-picryl-hydrazyl (DPPH), 2,2-azinobis(3-ethylbenzothiazoline-6-sulfonate) (ABTS), ferric ion reducing
antioxidant power (FRAP) and linoleic acid oxidation. The compounds were also assessed by ex vivo tests
to determine the acute toxicity, levels of thiobarbituric acid reactive species (TBARS), δ-aminolevulinate
dehydratase (δ-Ala-D) and Naþ/Kþ ATPase activities. The antidepressant-like activity of compounds in
the tail suspension test (TST) and forced swimming test (FST) was also investigated. The results
demonstrated that the addition of an organoselenium group to (R)-citronellal increased its antioxidant
properties, since PhSeCIT showed better activity than CIT. The treatment of mice with both compounds
did not cause death of any animals. The levels of TBARS were signiﬁcantly reduced by PhSeCIT in liver
and cortex of animals, whereas CIT did not alter these parameters. In the TST and FST, PhSeCIT showed
promising antidepressant-like activity, while CIT was not active in this test. Taken together, these data
demonstrate the role of selenium in the antioxidant and antidepressant-like activities of (R)-citronellal.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
The research with medicinal plants has been progressed
around the world, demonstrating the efﬁcacy of different plant
species (Zhang, 2004; Linde and Knnupel, 2005). Medicinal plants
have been an important resource for the development of drugs, for
example, the morphine from Papaver somniferum, ephedrine from
Ephedra vulgaris, and atropine from Atropa beladonna (Prakash and
Gupta, 2005). Indeed, nearly 25% of today's conventional drugs are
originated directly or indirectly from plants (Zhang, 2004).
The search for new bioactive compounds stimulates the researches
in new semi-synthetic compounds, including the synthesis of
selenium-derivatives from natural occurring compounds, like
selenium-containing polyphenolic acid esters (Lin et al., 2005), sele-
nium–tocopherol (Schiesser et al., 2001), selenium–carbohydrates
(Storkey et al., 2011; Affeldt et al., 2012) and butylated hydroxianisole
(BHA) derivatives with selenium (Shanks et al., 2006).
The interest in compounds containing selenium has increased in
the past three decades, mainly due to their biological activities
(Mugesh et al., 2008; Nogueira et al., 2004; Naziroglu and Yürekli,
2013). Selenium is necessary for the expression of at least 25
selenium-dependent enzymes, including the glutathione peroxidase
(Flohe, 1973), the thioredoxin reductase (Holmgren, 1989) and several
other selenoproteins that modulate the cellular redox and antioxidant
status (Ursini et al., 1990; Naziroglu, 2009; Naziroglu and Yürekli,
2013). The redox activity of selenium-containing molecules has been
suggested that they could provide antioxidants of considerable
potency (Nogueira et al., 2004; Parnham et al., 1991). Furthermore,
these compounds have neuroprotective properties (Brunning et al.,
2012; Moussaoui et al., 2000; Nogueira and Rocha, 2010; Pinton et al.,
2013), antidepressant and antioxidant activities (Gai et al., 2012;
Hassan et al., 2011; Jesse et al., 2011; Gerzson et al., 2012; Martinez
et al., 2013; Savegnago et al., 2013; Victoria et al., 2013).
Previous studies conducted by our group demonstrated the synth-
esis and antibacterial activity of α-phenylseleno citronellal (PhSeCIT).
It was observed that the addition of an organoselenium group to
(R)-citronellal improved its antibacterial activity when compared to
the parent, unmodiﬁed (R)-citronellal (CIT) (Victoria et al., 2009, 2012).
(R)-Citronellal (CIT) is a monoterpene predominantly formed during
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the secondary metabolism in plants. According to the literature this
compound possess antioxidant (Singh et al., 2002), antibacterial
(Elaissi et al., 2012) and antinociceptive effects (Quintans-Junior et
al., 2011).
Therefore, considering the effects of PhSeCIT observed in our
previous studies against a sort of pathogenic bacteria and the
paucity of data on this compound, we report here for the ﬁrst time
the antioxidant activity in vitro and ex vivo and the antidepressant-
like effect in vivo of α-phenylseleno citronellal (PhSeCT) and
natural occurring (R)-citronellal (CIT) (Fig. 1).
2. Material and methods
2.1. Drugs
α-Phenylseleno citronellal (PhSeCIT) was synthesized in our
laboratory according to the previously described method (Victoria
et al., 2009) and analysis of its GC/MS, 1H NMR and 13C NMR
spectra showed analytical and spectroscopic data in full agreement
with their assigned structures. (R)-Citronellal was obtained from
the essential oil of Cymbopogon nardus L. Rendle by reduced
pressure distillation. Chemical purity was determined by GC/MS
and was found to be 499.0%. Compounds were dissolved in
dimethylsulfoxide (DMSO) for the in vitro experiments and in
canola oil for the in vivo assays (at a constant volume of 10 mL/kg
body weight). Appropriate vehicle-treated groups were also simul-
taneously assessed. All other chemicals were of analytical grade
and obtained from standard commercial suppliers.
2.2. Animals
Adult male Swiss albino mice (25–35 g; 2–3 months of age)
were obtained from our own breeding colony. The animals were
maintained in an air conditioned room (20–25 1C) under a 12 h
light/dark cycle. All experimental procedures were conducted
according to the guidelines of the Committee of Ethics in Research
of the Federal University of Pelotas, Brazil (CEEA 2622). For in vivo
assays, the mice were acclimatized in the laboratory for at least 1 h
prior to testing, and each mouse was used only once during the
experiments. The experimental procedures were performed in
compliance with the National Institutes of Health Guide for Care
and Use of Laboratory Animals (Publication no. 85–23, revised
1985). After the experiments, the animals were euthanized by
cervical displacement. All efforts were made to minimize animal
suffering and to reduce the number of animals used in the
experiments.
2.3. In vitro antioxidant activity
2.3.1. Radical scavenging capacity
The ability of scavenging free radicals was measured by
following the reaction with stable reference free radicals 2,2-
diphenyl-1-picrylhydrazyl (DPPH) and 2,20-azinobis(3-ethylben-
zothiazoline-6-sulfonic acid) cation radical, ABTSþ .
DPPH is a stable free radical commonly used as a substrate to
evaluate in vitro antioxidant activity. Antioxidants can scavenge
radicals by hydrogen donation, which causes a decrease in DPPH
absorbance (Ancerewicz et al., 1998). Different concentrations of
PhSeCIT and CIT (10–500 μM) were mixed with a methanolic
solution of DPPH radical, resulting in a ﬁnal concentration of
85 μM DPPH, after reaction for 30 min and the absorbance of
resultant solution was measured at 517 nm (Choi et al., 2002).
The ABTSþ radical reacts quickly with electron-donors to form
colorless ABTS, and this assay is used to evaluate the presence of
several antioxidants (Re et al., 1999). Different concentrations of
PhSeCIT and CIT (10–500 μM) were mixed with ABTSþ solution,
and the mixture was left to stand for 30 min at 30 1C; the
absorbance was measured at 734 nm, according to the method
proposed by Re et al. (1999).
2.3.2. Ferric reducing antioxidant power (FRAP)
The FRAP of PhSeCIT and CIT was measured according to the
method described by Stratil et al. (2006) with slight modiﬁcations.
This assay measures the ability of compounds in reducing the
ferric 2,4,6-tripyridyl-s-triazine complex [Fe3þ-(TPTZ)2]3þ to the
intensely blue colored ferrous complex [Fe2þ-(TPTZ)2]2þ in acidic
medium (Benzie and Strain, 1996, 1999). Different concentrations
of compounds (10–1000 mM) and the FRAP reagent were added to
each sample and the mixture was incubated at 37 1C for 40 min in
dark. The absorbance of the resulting solution was measured at
593 nm using a spectrophotometer.
2.3.3. Thiobarbituric acid reactive species (TBARS) assay
Linoleic acid was used as a lipid matrix to evaluate the effect of
compounds on sodium nitroprusside (SNP)-induced lipid perox-
idation, according to the methodology proposed by Choi et al.
(2005). In this assay, linoleic acid peroxidation was initiated by the
addition of 100 mL of SNP (100 mM) and incubated for 30 min at
37 1C; the reaction was terminated by the addition of trichloroa-
cetic acid (5.5%). Then, 250 mL of the mixture was added to 250 mL
of thiobarbituric acid in 50 mM NaOH, followed by heating for
10 min. The mixtures were centrifuged at 3500g for 10 min and
the absorbance of thiobarbituric acid-reacting substances (TBARS)
in the supernatant was read at 532 nm.
2.4. In vivo experiments
2.4.1. Acute toxicity
To evaluate the possible toxic action of PhSeCIT and CIT, male
Swiss albino mice were randomly divided into four groups con-
sisting of 10 animals each. The mice received the compounds by
oral route at different doses (200 and 400 mg/kg) and the vehicle
(canola oil, 10 mL/kg). After the administration, animals were
observed for 72 h to determine the lethal dose of compounds for
50% of animals (LD50). In the end of time, it was determined the
gain in body weight and lethality as a signal of general toxicity.
After 72 h of exposure, the mice were euthanized by cervical
displacement, and the brain structures (hippocampus and cortex)
and liver were rapidly removed, homogenized (liver 1:10; v/v and
brain structures 1:5; v/v) and centrifuged. The S1 was separated
and used for ex vivo analysis of TBARS levels, δ-Ala-D and Naþ/Kþ
ATPase activities.
2.4.2. Thiobarbituric acid-reactive species (TBARS) assay
TBARS levels were determined as described by Ohkawa et al.
(1979). An aliquot of S1 was incubated with 0.8% thiobarbituric
acid (TBA), acetic acid buffer pH 3.4 and 8.1% sodium dodecil
Fig. 1. Chemical structure of PhSeCIT and CIT.
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sulfate at 95 1C for 2 h. The absorbance of the colored reaction
mixture was measured at 532 nm. TBARS levels were expressed as
nmol MDA/mg protein.
2.4.3. δ-Aminolevulinate dehydratase (δ-ALA-D) activity
Cerebral and hepatic δ-ALA-D activities were assayed by the
method of Sassa (1982) by measuring the rate of porphobilinogen
(PBG) formation (expressed as nmol PBG/mg protein/h) except
that 1 M potassium phosphate buffer, pH 6.8 and 12 mM of
aminolevulinic acid (ALA) were used. Incubations were carried
out for 30 min at 37 1C. The reaction product was evaluated using
modiﬁed Ehrlich's reagent at 555 nm, with a molar absorption
coefﬁcient of 6.1104 M1 for the Ehrlich-porphobilinogen salt.
2.4.4. Naþ/Kþ-ATPase activity
Immediately after the sacriﬁce of the animal, the brain structures
were removed and separated. The homogenate was prepared in
50 mM Tris–HCl buffer (pH 7.4). The homogenate was centrifuged at
4000g for 10 min and the supernatant was used for assay for protein
Naþ/Kþ-ATPase. The reaction was initiated by addition of ATP to a
ﬁnal concentration of 3.0 mM. Controls were carried out under the
same conditions with the addition of 0.1 mM ouabain. Naþ/Kþ-
ATPase activity was calculated as nmol Pi/mg protein/min by the
difference between the two assays. Released inorganic phosphate (Pi)
was measured by the method of Fiske and Subbarow (1925) and
protein amount was measured spectrophotometrically at 650 nm
using the method described by Lowry et al. (1951).
2.4.5. Antidepressant-like activity evaluation
The antidepressant-like properties of PhSeCIT was evaluated by
the tail suspension test (TST) (Steru et al., 1985) and forced
swimming test (FST) (Porsolt et al., 1977), which are predictive
models of antidepressant activity, in mice and compare with those
of CIT. Before the TST and FST, animals were submitted to the open
ﬁeld test (OFT). The OFT was also carried out to rule out any
psychostimulant effect of PhSeCIT and CIT.
2.4.5.1. Tail suspension test (TST). TST is a well characterized
behavioral model predictive of antidepressant activity. In this
test, animals are placed in an inescapable situation and the
antidepressant-like activity is expressed by the decrease of
immobility time, an effect that is exhibited by conventional
antidepressants (Cryan et al., 2002; Steru et al., 1985).
For this purpose mice were randomly divided and pre-treated by
oral route (p.o) with different doses of PhSeCIT (1, 10 and 100 mg/kg),
CIT (10 and 100 mg/kg), ﬂuoxetine (32 mg/kg) or canola oil (10 mL/kg)
30 min before the TST. Mice were suspended on the edge of a
table 50 cm above the ﬂoor by adhesive tape placed approximately
1 cm from the tip of the tail. Immobility time, deﬁned as the absence
of escape-oriented behavior, was scored over 6min as described
previously (Rodrigues et al., 2002; Mantovani et al., 2003).
2.4.5.2. Forced swimming test (FST). FST was conducted using a
slightly modiﬁed method described by Porsolt et al. (1977). This
test was performed to conﬁrm the possible antidepressant-like
activity of compounds.
Mice were randomly divided in four groups (6 animals each
group), and pre-treated by oral route with canola oil (10 mL/Kg,
vehicle of compounds), PhSeCIT (100 mg/Kg), CIT (100 mg/Kg) and
ﬂuoxetine (positive control, 32 mg/Kg). Brieﬂy, each mouse was
placed individually in a cylinder which was ﬁlled with 20 cm of
water (2271 1C) and was observed for a duration of 6 min. The
duration of immobility was recorded manually.
The mouse was considered immobile when it ﬂoated motion-
less or made only those movements necessary to keep its head
above the water surface (Porsolt et al., 1977). They were removed
and dried with a towel after the procedure. The water was
changed after each test.
2.4.5.3. Open ﬁeld test (OFT). The locomotor and exploratory
behavior was assessed in the OFT. The open ﬁeld was made of
polywood and surrounded by walls (30 cm in height). Masking tape
markers divided the ﬂoor of the open ﬁeld into 9 squares (3 rows of 3),
45 cm in length and 45 cm in width. Each animal was placed
individually at the center of the apparatus and observed for 5 min to
record the locomotor (number of segments crossed with the four
paws) and exploratory activities (expressed by the number of time
rearing on the hind limbs) (Walsh and Cummins, 1976).
2.5. Statistical analysis
The results are presented as means7standard error mean (S.E.M.).
Statistical analysis was performed using a one-way analysis of variance
(ANOVA) followed by the appropriate multiple comparison tests. The
in vitro assays were performed in duplicate and repeated at least three
times; for the in vivo assays, 10 animals were used per group.
Differences were considered statistically signiﬁcant at a P value of
0.05. The IC50 (concentration of sample required to inhibit 50% of lipid
peroxidation) and ID50 (dose necessary to reduce in 50% the immo-
bility time when compared to the control group) values were
calculated from the graph of % inhibition vs. concentration.
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Fig. 2. Ferric ion reducing antioxidant power (FRAP) of PhSeCIT (A) and CIT (B). Data are presented as the mean7S.E.M. of the absorbance values at 593 nm (n¼3). The data
were analyzed by one-way ANOVA followed by Tukey's multiple comparison test. (nnn) represents Po0.001, compared to the control group.
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3. Results
3.1. Effect of PhSeCIT and CIT on in vitro assays
In the FRAP assay, PhSeCIT presented signiﬁcant results in the
concentration equal and higher than 500 mM (Fig. 2), while CIT did
not presented any effect at the same concentrations.
Both compounds reduced the sodium nitroprusside (NPS)-
induced linoleic acid oxidation. PhSeCIT was effective starting at
concentrations of 50 mM and presented an IC50 of 265.0746.9 mM
and Imax of 68.978.5%. CIT showed signiﬁcant effects at concen-
trations equal and higher than 100 mM with a IC50 of
304.1724.7 mM and Imax of 68.1715.5% (Fig. 3). Based on these
results, it is possible to state that PhSeCIT is a more potent
antioxidant compound than CIT indicating that the addition of a
selenium organic group in the CIT molecule increased its antiox-
idant properties. PhSeCIT and CIT did not demonstrate scavenger
effect in the DPPH and ABTS assays (data not shown).
3.2. In vivo assays
3.2.1. Acute toxicity
A single oral administration of PhSeCIT and CIT at doses of 200 and
400 mg/kg did not cause death of any animal. Fig. 4 presents the body
weight gain of animals treated with PhSeCIT, which was signiﬁcantly
reduced in the dose of 400 mg/kg (Fig. 4A). The administration of CIT
did not alter the body weight in any administered dose (Fig. 4B).
3.2.2. Thiobarbituric acid-reactive species (TBARS) assay
Oral administration of the PhSeCIT (200 and 400 mg/kg)
reduced the hepatic peroxidation and the treatment with CIT did
not alter this parameter (Fig. 5A). In the cortex of the brain,
PhSeCIT reduced signiﬁcantly the lipid peroxidation at doses of
200 and 400 mg/kg, while CIT did not alter this parameter
(Fig. 5B). However, both compounds increased the levels of MDA
in hippocampus of mice after acute treatment (Fig. 5C).
3.2.3. δ-Aminolevulinate dehydratase (δ-ALA-D) activity
δ-ALA-D activity of mice's liver and brain structures was not
affected by the acute treatment with PhSeCIT. The treatment with
CIT promoted a reduction of δ-ALA-D in the mice's cortex at the
higher dose (400 mg/kg) and no alteration was observed in the
other tissues (Table 1).
3.2.4. Naþ /Kþ-ATPase activity
As can be seen in Fig. 6, the activity of Naþ/Kþ-ATPase was not
modiﬁed in mice hippocampus and cortex by the acute treatment
with different doses of PhSeCIT and CIT.
3.2.5. Antidepressant-like activity
The acute administration of PhSeCIT produced an anti-
depressant-like effect (reduced the immobility time) in the TST
in doses equal and higher than 10 mg/kg, as ﬂuoxetine (32 mg/kg)
(Fig. 7A). The dose of PhSeCIT that inhibits 50% of response (ID50)
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Fig. 3. Effect of PhSeCIT (A) and CIT (B) on SNP-induced linoleic acid lipid oxidation assay. Data are presented as the mean7S.E.M. (n¼3). The values are expressed as a % of
oxidation. The IC50 indicates the necessary concentration to inhibit 50% of lipid peroxidation. The Imax is the maximal inhibition offered by the compounds. (n) represents
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Fig. 4. Effect of an acute treatment with PhSeCIT (A) and CIT (B) in the body gain weight of mice. Data are presented as the mean7S.E.M. (n¼6) and were analyzed by one-
way ANOVA followed by Tukey's multiple comparison tests. (nnn) represents Po0.001.
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was 48.6771.85 mg/kg and the maximum inhibition (Imax) of
compound in the TST was 45.6070.54%. CIT, in its turn, did not
present any effect in TST, as can be seen in Fig. 7B.
In the FST, PhSeCIT also demonstrated antidepressant-like
activity at the dose of 100 mg/kg, with a value of Imax of
31.471.35%, as can be seen in Fig. 7C. This data conﬁrmed the
results obtained in TST, that PhSeCIT possess effect in tests of
antidepressant-like activity.
These results are in agreement with those observed in the
antioxidant studies, which demonstrated the role of an organose-
lenium group in the pharmacological properties of PhSeCIT, since
CIT did not present any effect in these assays.
3.2.6. Open ﬁeld test (OFT)
In order to rule out an interference of the locomotor activity in
the interpretation of the results obtained in TST and FST, the
ambulatory behavior was assessed in an open-ﬁeld test as pre-
viously described. The pre-treatment with PhSeCIT (1–100 mg/kg),
CIT (10 and 100 mg/kg) and ﬂuoxetine (32 mg/kg) did not sig-
niﬁcantly alter the exploratory and locomotor activities of mice
(data not shown).
4. Discussion
In the present work, we demonstrate the antioxidant effect of
PhSeCIT, an organoselenium compound, through in vitro and
ex vivo assays and all the results were compared with the parent,
unmodiﬁed, (R)-citronellal. The compound with selenium demon-
strated potential antioxidant effect when compared with CIT. Thus,
based on these results we extend our studies about the pharma-
cological potential of PhSeCIT, using the TST and FST to evaluate its
possible antidepressant-like effect in mice. PhSeCIT showed pro-
mising results as an antidepressant in this test. Considering that
the synthesis of this compound was recently reported (Victoria
et al., 2009) and since there was no toxicological data (acute)
available for PhSeCIT, we reported here, for the ﬁrst time, its acute
toxicological data.
The current study shows that the addition of an organosele-
nium compound to CIT, improved its ability in reducing ferric ions,
in the FRAP assay (Fig. 2). PhSeCIT demonstrated signiﬁcant effect
at concentrations equal and higher than 500 mM. Ferric ions (Fe3þ)
can produce radicals from peroxides, so the reducing power can
reﬂect the ability of compounds to modulate redox tone in plasma
and tissues (Gülçin, 2012). The mechanism of FRAP assay is totally
electron transfer and the ability to reduce iron has little relation-
ship to the radical quenching processes (hydrogen transfer)
mediated by most antioxidants (Gülçin, 2012). The reducing
capacity of a compound may serve as a signiﬁcant indicator of
its potential antioxidant activity (Gülçin et al., 2010).
As other novel result of the current study, PhSeCIT was more
potent (IC50 value: 265.0746.9 mM) than CIT (304.1724.7 mM)
(Fig. 3) in reducing the linoleic acid oxidation induced by SNP
(Fig. 3). SNP is a classical inductor of lipid peroxidation (Rauhala et
al., 1998) since it releases in a short-lasting time NO (Bates et al.,
1991). The oxidation of linoleic acid generates linoleic acid hydro-
peroxides, which decompose to secondary oxidation products
(Gülçin, 2012). The resulting lipid hydroperoxides can affect
membrane ﬂuidity and the function of membrane proteins
through a series of free radical mediated chain reaction processes
and are also associated with several types of biological damage
(Perry et al., 2000).
In this study, we have found that the administration of PhSeCIT
and CIT did not caused death during the treatment (72 h). PhSeCIT
at the higher dose (400 mg/kg) reduced the body weight of
animals, however it is important emphasize that the dose that
reduced body weight of animal is 40 times higher than the
pharmacological dose (10 mg/kg, dose that showed effect on the
TST). In fact, according to Nogueira et al. (2004), selenium
compounds are considered “Janus compounds”, i.e., products with
a double face, because of their contrasting behavior that is dose
dependent. At low doses, organoselenium has beneﬁcial effects,
whereas at high doses it is toxic. The threshold dose for these
opposing properties has not yet been established. Furthermore,
Kennedy (2006) related that initial antidepressant treatment may
be associated with weight loss, a fact that could be related to the
serotonergic regulation that induces temporary carbohydrate
intolerance and the stimulation of 5-HT receptors that appear to
promote satiety.
The biochemical analysis of tissues of mice treated with
PhSeCIT and CIT revealed that PhSeCIT reduced the hepatic lipid
peroxidation at doses of 200 and 400 mg/kg, while CIT did not
promote any alteration (Fig. 5). According to Knight et al. (2001)
the role of oxidative stress was reported to be one of the important
factors in the development of hepatic cell injury. In the brain
structures, PhSeCIT was effective in reducing lipid peroxidation in
the cortex of the brain at doses equal and higher than 200 mg/kg,
whilst CIT did not alter the lipid peroxidation. However, both
compounds enhanced the levels of MDA in hippocampus of mice,
0
10
20
30
40
50
Control
200 mg/kg
400 mg/kg
*
PhSeCIT       CIT
*
nm
ol
 M
D
A
/m
gp
tn
0
50
100
150
Control
200 mg/kg
400 mg/kg
* *
PhSeCIT       CIT
nm
ol
 M
D
A
/m
gp
tn
0
50
100
150
200
Control
200 mg/kg
400 mg/kg
**
**
***
PhSeCIT       CIT
nm
ol
 M
D
A
/m
gp
tn
Liver
Córtex
Hippocampus
Fig. 5. Effect of the PhSeCIT and CIT on lipid peroxidation in the liver (A), cortex
(B) and hippocampus (C) of mice. Values are expressed as nmol of MDA/mg protein.
Each value is expressed as the mean7S.E.M. (n¼6). Asterisks represent signiﬁcant
effects (nPo0.05, nnPo 0.01 and nnnPo0.001) compared with the respective
control without the tested compounds by one-way ANOVA followed by Tukey's
multiple comparison test when appropriate.
F.N. Victoria et al. / European Journal of Pharmacology 742 (2014) 131–138 135
PhSeCIT at a dose of 400 mg/kg and CIT at doses equal and higher
than 200 mg/kg. It is important to note that the enhancement of
MDA levels was more pronounced in mice that received CIT, since
as can be seen CIT increased the lipid peroxidation at the lowest
dose (200 mg/kg). Based on this fact, we believed that the increase
in lipid peroxidation of mice hippocampus is related to CIT, and
the presence of an organoselenium group reduced this increase.
This result corroborates others studies that, depending on the
dose/concentration, organoselenium compounds may act as an
antioxidant or a pro-oxidant (Nogueira and Rocha, 2010, 2011)
PhSeCIT administered orally did not inhibit the δ-Ala-D activity in
liver, cortex and hippocampus. The treatment of mice with CIT
inhibited the δ-Ala-D activity in cortex, while no change was
observed in liver and hippocampus (Table 1). δ-Ala-D is a
sulfhydryl-containing enzyme that is extremely sensitive to oxi-
dizing agents (Barnard et al., 1977). Organoselenium compounds
can interact directly with low molecular thiols, oxidizing them to
disulﬁdes, which may cause, in the case of enzymes, the loss of
their catalytic activity (Barnard et al., 1977).
Another sulfydryl-containing enzyme sensitive to oxidizing
agents is the Naþ/Kþ-ATPase. Naþ/Kþ-ATPase is responsible for
the active transport of Naþ and Kþ ions in membrane and thus
regulates the cellular Naþ/Kþ concentrations, essential for ionic
balance in the tissues (Jorgensen and Collins, 1986). In fact, –SH
groups of this enzyme are highly susceptible to oxidizing agents
(Carfagna et al., 1996; De Assis et al., 2003) which turns the
Table 1
Effect of the acute treatment with PhSeCIT and CIT on δ-Ala D activity.
Tissue PhSeCIT CIT
Control 200 mg/kg 400 mg/kg Control 200 mg/kg 400 mg/kg
Hippocampus 14.3972.25 29.0275.43 30.4575.41 14.3972.25 18.1274.30 22.1078.05
Cortex 21.2473.07 21.6272.61 21.6873.04 21.2473.07 16.4271.60 12.5471.96a
Liver 7.7070.71 7.6770.58 6.5270.39 7.7070.71 7.5370.58 8.4370.41
The values are expressed as mean7S.E.M. (n¼10). Data were analyzed by one-way ANOVA followed by the Tukey's multiple comparison test. Small letter represent
signiﬁcant difference (Po0.5) from the respective control.
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Fig. 6. Effect of an acute treatment with PhSeCIT and CIT on the Naþ/Kþ ATPase activity on cortex (A, B) and hippocampus (C, D) of mice, respectively. Values are expressed
as nmol of inorganic phosphate by milligram of protein. Each value is expressed as the mean7S.E.M. (n¼6). Data were analyzed by one-way ANOVA.
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enzyme potentially sensitive to organoselenium compounds. The
pre-treatment with PhSeCIT and CIT did not alter the Naþ/Kþ-
ATPase in cortex and hippocampus of mice (Fig. 6).
Based on the promising results of PhSeCIT, in vitro antioxidant
activity and lack of toxic effects in the tests carried out, we extend
the studies to the evaluation of the possible antidepressant-like
activity of PhSeCIT in the TST (Fig. 7).
Depression is one of the most commonly diagnosed mental
disorders among adults. Our understanding of the course and
nature of depression has changed signiﬁcantly in the last 20 years.
From being seen as an acute and self-limiting illness, to a growing
clarity that for many depressions are now considered a chronic,
lifelong illness (Richards, 2011).
The results showed that PhSeCIT possess antidepressant-like
activity in the TST at doses equal and higher than 10 mg/kg and in
FST at the dose of 100 mg/kg. Indeed, the results of immobility
time of PhSeCIT are not signiﬁcantly different from ﬂuoxetine
(32 mg/kg, a classical antidepressant drug). On the other hand, CIT
did not present effect on the TST and FST, demonstrating that the
addition of an organoselenium to the molecule of (R)-citronellal is
responsible for the biological activity.
Based on the observations above, our data reveal that the addition
of an organoselenium moiety improves the pharmacological proper-
ties of (R)-citronellal. Furthermore, in the search for new molecules
useful for the treatment of neurological disorders, organoselenium
compounds have demonstrated pharmacological potential (Brüning
et al., 2011; Gerzson et al., 2012).
5. Conclusion
The in vitro data presented here provide for the ﬁrst time
concrete experimental data about the antioxidant effect of PhSe-
CIT. The present work also demonstrated the in vivo antioxidant
potential of PhSeCIT, lack of toxicological effects and the
antidepressant-like activity. Thus, we speculate that PhSeCIT
might be of interest as an antioxidant and/or antidepressant agent
for treatment of depression.
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